Leading Proxy Advisory Firm ISS Recommends Kindred Stockholders Vote “FOR” the Transaction with TPG Capital, Welsh, Carson, Anderson & Stowe and Humana Inc.
Kindred Reminds Stockholders to Vote “FOR” the Value Maximizing Transaction Today
Commenting on the report,
Kindred continues to expect the transaction to close in the summer of 2018.
Kindred’s special meeting of stockholders is scheduled to take place on
Kindred reminds stockholders that their vote is important, no matter how many shares they own. The Kindred Board unanimously recommends that all Kindred stockholders vote “FOR” the proposal to adopt the merger agreement as well as all other proposals included in the definitive proxy statement. Kindred reminds investors that failing to vote or abstaining from voting is effectively a vote against the transaction.
Kindred stockholders who have questions, need assistance in voting their proxy card or require replacement proxy materials may contact Kindred’s proxy solicitors:
Your Vote Is Important, No Matter How Many Shares You Own!
|If you have questions about how to vote your shares, please contact:|
MacKenzie Partners, Inc.
1407 Broadway, 27th Floor, New York, New York 10018
(212) 929-5500 or Toll-Free (800) 322-2885
This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are often identified by words such as “anticipate,” “approximate,” “believe,” “plan,” “estimate,” “expect,” “project,” “could,” “would,” “should,” “will,” “intend,” “hope,” “may,” “potential,” “upside,” “seek,” “continue” and other similar expressions.
Such forward-looking statements are inherently uncertain, and
stockholders and other potential investors must recognize that actual
results may differ materially from Kindred’s expectations as a result of
a variety of factors. Such forward-looking statements are based upon
management’s current expectations and include known and unknown risks,
uncertainties and other factors, many of which Kindred is unable to
predict or control, that may cause Kindred’s actual results,
performance, or plans to differ materially from any future results,
performance or plans expressed or implied by such forward-looking
statements. Risks and uncertainties related to the proposed transactions
include, but are not limited to, the occurrence of any event, change or
other circumstance that could give rise to the termination of the merger
agreement; the failure of the parties to satisfy conditions to
completion of the proposed merger, including the failure of Kindred’s
stockholders to approve the proposed merger or the failure of the
parties to obtain required regulatory approvals; the risk that
regulatory or other approvals are delayed or are subject to terms and
conditions that are not anticipated; changes in the business or
operating prospects of Kindred or its homecare business or hospital
business; changes in healthcare and other laws and regulations; the
impact of the announcement of, or failure to complete, the proposed
merger on our relationships with employees, customers, vendors and other
business partners; and potential or actual litigation. In addition,
these statements involve risks, uncertainties, and other factors
detailed from time to time in Kindred’s Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed
Many of these factors are beyond Kindred’s control. Kindred cautions investors that any forward-looking statements made by Kindred are not guarantees of future performance. Kindred disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.
Additional Information and Where to Find It
Kindred has filed with the
Participants in the Solicitation
Kindred and its directors and executive officers may be deemed to be
participants in the solicitation of proxies from Kindred’s stockholders
in connection with the proposed merger. Information about Kindred’s
directors and executive officers, including information regarding the
interests of these directors and executive officers in the proposed
merger, is included in Kindred’s definitive proxy statement, which was
filed with the
Kindred Healthcare, Inc.
Susan E. Moss, 502-596-7296
Kindred Corporate Communications
Investors and Analysts
Todd Flowers, 502-596-6569
Kindred Investor Relations